
- Applied Clinical Trials-04-01-2007
- Volume 0
- Issue 0
eShowcase: Oracle Remote Data Capture Onsite
New data entry interface runs on top of existing software for accelerated navigation
New data entry interface runs on top of existing software for accelerated navigation
Oracle Corp. (Redwood Shores, CA) introduced Remote Data Capture Onsite, its next-generation EDC system data collection for clinical trial investigative sites. The interface is designed to accelerate and simplify the collection of clinical data and EDC deployment at investigative sites.
The new Oracle interface runs on top of its existing software product Oracle Remote Data Capture v4.5.1 for more intuitive data entry and navigation of CRFs. The interface allows site personnel to easily locate and update patient information and data entry, as well as add pages to the CRF. The system performs immediate online edit checks, which involves a discrepancy management module from the CRF to capture, route, and resolve discrepancies if applicable.
The Onsite interface features graphic icons that illustrate the status of CRF data. It also enables electronic messaging between users, CRF verifications as a group or individually, and backup approvals with e-signatures.
Oracle Corp., (650) 506-8920,
Articles in this issue
over 18 years ago
Clinical Trial Opportunities in Chinaover 18 years ago
Mission Possible: Rebranding Clinical Researchover 18 years ago
Investigators as Suppliersover 18 years ago
The UK Debate over Recruitment Strategiesover 18 years ago
Creating a Successful Central Metrics Groupover 18 years ago
eShowcase: ISI Solutions Platformover 18 years ago
eShowcase: Velos eResearch Version 7over 18 years ago
EU Approach to Safety: Vox Populi or Vox Dei?over 18 years ago
Industry Trials Poised to Win Back Academiaover 18 years ago
Adapt to Adaptive DesignsNewsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.